Phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

Manufacturer
Bieffe Medital S.p.A(ITALY)

Registraction Number
MAL19116023AZ

Content:

• Active Ingredients:
  • Calcium chloride dihydrate
  • Magnesium chloride hexahydrate
  • Sodium chloride
  • Sodium hydrogen carbonate
  • Potassium chloride
  • Disodium phosphate dihydrate

• Primary Use: Used in Continuous Renal Replacement Therapy (CRRT) for critically ill patients with acute renal failure (ARF) when pH and kalaemia have been restored to normal. It is also indicated for phosphate supplementation in cases of loss of phosphate in the ultrafiltrate or dialysate during CRRT. Additionally, it may be used in cases of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane.

• Dosage: The volume and rate of administration depend on the patient's clinical condition, blood concentration of phosphate and other electrolytes, acid-base balance, and fluid balance. The dose volume is determined by the responsible physician.
• Administration: Phoxilium is administered intravenously into the extracorporeal circuit before (pre-dilution) or after the haemofilter or haemodiafilter (post-dilution).
• Precautions: Do not use in cases of hyperkalaemia, metabolic alkalosis, or hyperphosphataemia. Avoid use if haemofiltration cannot correct symptoms caused by high blood urea concentration (uraemic symptoms).